Skip to main content
Ortivus logo

Ortivus — Investor Relations & Filings

Ticker · ORTI ISIN · SE0000188930 LEI · 549300AVDV7UC14MTH79 ST Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2023-08-25 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ORTI

About Ortivus

https://www.ortivus.com/

Ortivus is a medical technology company that develops and supplies mobile solutions for prehospital and emergency medical care. The company's core product is MobiMed, an advanced electronic Patient Care Record (ePCR) system designed for paramedics and emergency medical services (EMS) providers. MobiMed facilitates real-time documentation and data sharing directly from the field. The platform integrates with a wide range of medical devices, such as patient monitors and defibrillators, as well as with hospital patient administration systems and national health registries. This ensures seamless information flow across the entire care pathway. Key functionalities include structured workflows, automated risk assessments, secure communication, and a web portal for real-time incident overviews. The system also supports telemedicine capabilities, including video consultations. By optimizing documentation and providing actionable insights, Ortivus solutions aim to improve patient safety, enhance care quality, and increase operational efficiency for healthcare organizations.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Kvartalsrapport' (Quarterly Report) and covers the period from April to June 2023. It contains detailed financial statements, including income statements, cash flow analysis, and balance sheet data for the group and parent company. It provides a comprehensive review of business performance, market events, and financial metrics, which fits the definition of an Interim/Quarterly Report (IR). Q2 2023
2023-08-25 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' and covers the period April - June 2023. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance. It is not an announcement of a report (RPA) because it contains the full substantive financial data itself. It fits the definition of an Interim/Quarterly Report (IR). Q2 2023
2023-08-25 English
Ortivus signs an agreement with the main shareholder covering a credit line of 8 MSEK
Capital/Financing Update Classification · 95% confidence The document announces a specific corporate action: Ortivus entering into an agreement with its main shareholder for an 8 MSEK credit line to enhance liquidity. This is a material event related to the company's financing and capital structure. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS). It directly relates to fundraising or capital structure changes, fitting best under 'Capital/Financing Update' (CAP). The document is short and appears to be a press release announcing the event, rather than a detailed regulatory filing detailing the terms, but the core subject matter is financing.
2023-08-24 English
Ortivus ingår avtal med huvudägare avseende en kreditram om 8 MSEK
Capital/Financing Update Classification · 98% confidence The document announces that Ortivus has entered into an agreement with its main shareholder, Ponderus Invest, regarding a credit facility of 8 MSEK to strengthen liquidity due to delayed payments. The text explicitly states, "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such information that Ortivus is obliged to disclose pursuant to the EU Market Abuse Regulation). This indicates a mandatory regulatory disclosure concerning financing/capital structure. Since it is a specific announcement about securing financing (a credit facility), it fits best under 'Capital/Financing Update' (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given the nature of the announcement regarding a credit facility, CAP is the most appropriate classification.
2023-08-24 Swedish
Kontraktet avseende leverans av MobiMed Life till Region Kronoberg har nu undertecknats
Regulatory Filings Classification · 100% confidence The document announces that a previously reported contract for the delivery of MobiMed Life defibrillators to Region Kronoberg has now been signed. It details the contract length (2 years + extension options) and value (4.9 MSEK). The text concludes with a statement indicating that this information is being made public pursuant to the EU Market Abuse Regulation ('EU:s marknadsmissbruksförordning') and provides a link to a PDF attachment. This structure—a brief announcement of a material event, often referencing a prior event and concluding with regulatory disclosure language—is characteristic of a general regulatory announcement or press release that doesn't fit a specific financial report category (like 10-K, ER, or IR). Since it is a specific, material corporate event disclosure that doesn't map to the more specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (3819 chars) and it announces the finalization of an event, rather than being the full report itself.
2023-08-18 Swedish
The contract for the delivery of MobiMed Life to Region Kronoberg has been officially signed
Regulatory Filings Classification · 100% confidence The document announces the official signing of a contract for the delivery of MobiMed Life defibrillators to Region Kronoberg, following a previous award announcement. It details the contract duration, value (4.9 MSEK), and includes quotes from management. Crucially, the final line states: "This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly suggests a mandatory regulatory disclosure. Since the content is a specific business update (contract signing) rather than a general financial report (10-K, IR) or a proxy/dividend notice, and it is not a transcript (CT) or a management discussion (MDA), it fits best under the general regulatory announcement category, which is RNS (Regulatory Filings). It is not a Report Publication Announcement (RPA) because it is the primary announcement of the event, not just an announcement that a report is attached (though a PDF link is present, the core text is the news itself).
2023-08-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.